Scott Baumgartner
Impact in
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
Papers in
- Nephrology 23
- Gout, Hyperuricemia, Uric Acid 23
-
- Rheumatoid Arthritis Research and Therapies 3
- Spondyloarthritis Studies and Treatments 1
- Co-authors
- James G. Krueger (1 shared paper)Elizabeth H. Z. Thompson (1 shared paper)Chris B. Russell (1 shared paper)Alan Menter (1 shared paper)Gregory Kricorian (1 shared paper)Girish A. Aras (1 shared paper)Jean Paul Ortonne (1 shared paper)Juan Li (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (4 papers)Lara D. Veeken (3 papers)Arthritis Care & Research (2 papers)Arthritis & Rheumatology (2 papers)Arthritis Research & Therapy (2 papers)
- Partner nations
- United StatesNew ZealandCanada
In The Last Decade
Scott Baumgartner
30 papers receiving 2.1k citations
Scott Baumgartner's Hit Papers
Peers
Comparison fields: 5 of 74
- Nephrology 964
- Immunology 652
- Rheumatology 286
- Dermatology 34
- Ophthalmology 39
Countries citing papers authored by Scott Baumgartner
This map shows the geographic impact of Scott Baumgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Baumgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Baumgartner more than expected).
Fields of papers citing papers by Scott Baumgartner
This network shows the impact of papers produced by Scott Baumgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Baumgartner. The network helps show where Scott Baumgartner may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Baumgartner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis Hit paper breakdown → | 2012 | 819 |
| 2 | 2016 | 154 | |
| 3 | 2016 | 139 | |
| 4 | 2017 | 134 | |
| 5 | 2017 | 100 | |
| 6 | 2015 | 95 | |
| 7 | 2014 | 88 | |
| 8 | 2009 | 83 | |
| 9 | 2015 | 67 | |
| 10 | 2011 | 60 | |
| 11 | 2017 | 49 | |
| 12 | 2018 | 46 | |
| 13 | 2011 | 42 | |
| 14 | 2009 | 31 | |
| 15 | 2015 | 29 | |
| 16 | 2016 | 29 | |
| 17 | 2018 | 29 | |
| 18 | 2018 | 26 | |
| 19 | 2018 | 22 | |
| 20 | 2019 | 21 |
About Scott Baumgartner
Scott Baumgartner is a scholar working on Nephrology, Rheumatology, Immunology, Dermatology and Nutrition and Dietetics, having authored 30 papers that have together received 2.2k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (23 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Dermatology and Skin Diseases (1 paper), Autoimmune and Inflammatory Disorders (1 paper), Fatty Acid Research and Health (1 paper) and Spondyloarthritis Studies and Treatments (1 paper). The work is most often cited by research in Nephrology (964 citations), Immunology (652 citations), Rheumatology (286 citations), Dermatology (34 citations) and Ophthalmology (39 citations). Scott Baumgartner has collaborated with scholars based in United States, New Zealand and Canada. Frequent co-authors include James G. Krueger, Elizabeth H. Z. Thompson, Chris B. Russell, Alan Menter, Gregory Kricorian, Girish A. Aras, Jean Paul Ortonne, Juan Li, Craig L. Leonardi and Kim Alexander Papp. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Care & Research, Arthritis & Rheumatology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.